Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CTLT Catalent > Detailed Quotes

CTLT Catalent

74.730
-1.340-1.76%
Close 09/26 16:00 ET
74.7300.0000.00%
Pre Mkt Price 09/27 07:17 ET
High
78.560
Open
75.170
Turnover
156.00M
Low
73.890
Pre Close
76.070
Volume
2.08M
Market Cap
13.44B
P/E(TTM)
26.31
52wk High
140.555
Shares
179.90M
P/E(Static)
26.31
52wk Low
73.890
Float Cap
13.33B
Bid/Ask %
-84.62%
Historical High
142.640
Shs Float
178.39M
Volume Ratio
1.20
Historical Low
18.920
Dividend TTM
--
Div Yield TTM
--
P/B
2.80
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.17%
Amplitude
6.14%
Avg Price
74.891
Lot Size
1
Float Cap
13.33B
Bid/Ask %
-84.62%
Historical High
142.640
Shs Float
178.39M
Volume Ratio
1.20
Historical Low
18.920
Dividend TTM
--
P/B
2.80
Dividend LFY
--
Turnover Ratio
1.17%
Amplitude
6.14%
Avg Price
74.891
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment offers formulation, development, and manufacturing services for soft capsules or softgels, as well as large-scale production of oral solid dose forms for pharmaceutical and consumer health markets and supporting ancillary services. The Biologics segment develops and produces biologic cell-line, cell therapy, and viral vector gene therapy, formulation for parenteral dose forms, which include prefilled syringes, vials, and cartridges, and analytical development and testing services for large molecules. The Oral and Specialty Delivery segment is composed of advanced formulation of a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is involved in packaging, storage, distribution, and inventory management of drugs and biologics in clinical trials. The company was founded in 1933 and is headquartered in Somerset, NJ.
CEO: Mr. Alessandro Maselli
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...